MedTrace Logo

Safety Study of Transmyocardial Revascularization (TMR) With Bone Marrow Aspirate (BMAC) for Angina Reduction

NCT01285297 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2015-08-19

No results posted yet for this study

Summary

The purpose of this study is to determine the safety of injecting autologous bone marrow concentrate with laser transmyocardial revascularization (TMR) for treatment of angina which cannot be treated by direct coronary intervention.

Conditions

  • Angina

Interventions

BIOLOGICAL

Bone Marrow Aspirate Concentrate

Injection of up to 18 mL BMAC

Sponsors & Collaborators

  • Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc.

    lead INDUSTRY

Principal Investigators

  • Keith B Allen, MD · Clinical Advisor

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • Russia
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01285297 on ClinicalTrials.gov